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Abstract
Background: The blood hyperserotonemia of autism is one of the most consistent biological
findings in autism research, but its causes remain unclear. A major difficulty in understanding this
phenomenon is the lack of information on fundamental interactions among the developing brain,
gut, and blood in the mammalian body. We therefore investigated relationships among the body
mass, the brain mass, the volume of the hippocampal complex, the gut length, and the whole-blood
levels of tryptophan and 5-hydroxytryptamine (5-HT, serotonin) in young, sexually immature wild-
type mice.
Results: Three-dimensional reconstructions of the hippocampal complex were obtained from
serial, Nissl-stained sections and the gut was allowed to attain its maximal relaxed length prior to
measurements. The tryptophan and 5-HT concentrations in the blood were assessed with high-
performance liquid chromatography (HPLC) and the sex of mice was confirmed by genotyping.
Statistical analysis yielded information about correlative relationships among all studied variables. It
revealed a strong negative correlation between blood 5-HT concentration and body mass and a
strong negative correlation between the brain mass/body mass ratio and gut length. Also, a negative
correlation was found between the volume of the hippocampal complex and blood tryptophan
concentration.
Conclusion: The study provides information on the covariance structure of several central and
peripheral variables related to the body serotonin systems. In particular, the results indicate that
body mass should be included as a covariate in studies on platelet 5-HT levels and they also suggest
a link between brain growth and gut length.
Background
The present study was motivated by the platelet hyperser-
otonemia of autism, a long-standing problem in autism
research. It is an extension of our previous experimental
and theoretical investigations [1-3] that suggest that the
platelet hyperserotonemia is inherently a systems prob-
lem in that it requires understanding relationships among
various components of the peripheral serotonin (5-
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hydroxytryptamine, 5-HT) system and the developing
brain.
The platelet hyperserotonemia of autism is defined as ele-
vated 5-HT levels in the blood platelets of individuals
diagnosed with autism spectrum disorders (ASDs) [4-6].
To date, this finding has been replicated by many studies
in ethnically diverse autistic groups [7-15]. While a
number of genes may contribute to ASD risk [16-21], the
replicability of the platelet hyperserotonemia suggests
that these genes may affect a small set of biological net-
works [3,22].
The 5-HT sequestered in platelets is synthesized from tryp-
tophan by enterochromaffin cells in the gut wall [23],
with negligible contribution from serotonergic neurons of
the enteric nervous system [24]. Some of the gut 5-HT dif-
fuses into the systemic blood circulation, where most of it
is rapidly cleared by the liver and lungs [25,26]. The
remaining free 5-HT in the blood plasma can be taken up
by platelets that express the serotonin transporter (SERT).
Early studies have suggested that the platelet hypersero-
tonemia of autism may be caused by altered function of
SERT in blood platelets [27]. More recent research has
shown that SERT polymorphic variants do partially deter-
mine platelet 5-HT uptake rates [28], but that these poly-
morphisms, alone, do not cause the platelet
hyperserotonemia of autism [28,29] or contribute to
autism itself [10,30-33]. Other studies have suggested that
the platelet hyperserotonemia may be caused by altered 5-
HT production in the gut [1,34-37], but current experi-
mental evidence remains inconclusive. Also, no link
between platelet hyperserotonemia and increased intesti-
nal permeability has been found in children with perva-
sive developmental disorders [38].
Several studies have recently proposed that the platelet
hyperserotonemia of autism may be caused by interac-
tions among several components of the peripheral 5-HT
system [2,14,37,39]. Specifically, the amount of 5-HT
stored in blood platelets may depend on the dynamic
interplay among the gastrointestinal system, blood circu-
lation, vascular beds, and platelets themselves [2]. Under-
standing these interactions in the peripheral 5-HT system
may lead to new insights into the normal function of the
central nervous system. Tryptophan, the 5-HT precursor,
is actively transported across the blood-brain barrier
(BBB) and, while 5-HT is generally thought to not cross
the BBB, some transfer may occur at elevated 5-HT con-
centrations [40]. Brain neurons express the same SERT as
platelets [41], and SERT is also expressed by brain
endothelial cells [42,43]. Also, brain and enteric neurons
express many of the same serotonin receptors [44].
Our previous theoretical investigation has shown that
platelet 5-HT levels may be a function of a number of
parameters and their interactions, among them the vol-
ume of the circulating blood and the length of the gut [2].
Based on these previous findings, we investigated correla-
tive relationships among several key components of the
peripheral 5-HT system and the brain in young, sexually
immature mice. Specifically, we measured the body mass,
the brain mass, the volume of the hippocampal complex,
the relaxed gut length, and the whole-blood 5-HT and
tryptophan levels in the same individual wild-type mice at
two weeks after birth. In this study, the hippocampal com-
plex served as a convenient brain structure the borders of
which are clearly defined in Nissl-stained sections. The
hippocampal complex may also play a role in ASDs [45-
47].
The principal aim of the present study was to reveal the
system's covariance structure [48] which can guide exper-
imental design and can be used in advanced, causal mod-
eling. Therefore, strong emphasis was placed on statistical
power in an effort to obtain reasonably accurate correla-
tion coefficients, rather than merely significant or non-sig-
nificant results [49]. One of the advantages of this
approach is that the obtained covariance matrix can be
combined with results of future studies and used in struc-
tural equation modeling, a powerful modeling technique
for complex systems.
The focus of the present study was restricted to a postnatal
developmental time that may offer insights into central
and peripheral alterations in ASDs. We have previously
shown that, by two weeks after birth, 5-HT1A receptor-
knockout mice develop platelet hyperserotonemia [1].
Studies in rats suggest that at this time the development of
the hippocampus and the cerebellum are strongly control-
led by the state of the brain serotonin system. In the first
two postnatal weeks, the expression of 5-HT1A receptors
increases in the forebrain, but strongly decreases in the
cerebellum [50]. Between postnatal days 10 and 21, the
expression of 5-HT1A receptors in the pyramidal cells of
the hippocampus shifts from somatic to dendritic and,
between postnatal days 10 and 16, the expression of 5-
HT1A receptors in S100-positive hippocampal astrocytes
declines from 90% to 20% [51]. The binding of 5-HT4
receptors in the globus pallidus and the substantia nigra
sharply increases between postnatal days 9 and 12 and
then strongly decreases between postnatal days 12 and 21
[52]. Even though little is known about whether similar
changes occur in the human brain, they appear likely
since the 5-HT1A expression in the human cerebellum
shifts from high in the neonatal stage to very low in adult-
hood [53] resembling the developmental pattern of 5-
HT1A receptor expression in rats [50].BMC Physiology 2009, 9:4 http://www.biomedcentral.com/1472-6793/9/4
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Methods
Animals
Timed-pregnant, wild-type CD-1 mice were purchased
from Charles River Laboratories, Inc. (Wilmington, MA).
They arrived at 15–17 days of gestation and were housed
in the UCSB animal facility in individual cages on a 12:12
light-dark cycle (lights on at 07:00, off at 19:00). Mice
were checked every morning (before 12:00) and the deliv-
ery day was considered to be postnatal day (PD) 0. The
pups were kept with the dam until used. Pups from six lit-
ters were analyzed. All litters were normal size (12–14
pups). All experiments were approved by the UCSB Insti-
tutional Animal Care and Use Committee.
Tissue harvesting
A total of 63 pups from 6 litters were used in the study. At
postnatal day 14 (5 litters) or 15 (1 litter), individual pups
were removed from the cage, weighed, and immediately
decapitated. The trunk blood was collected into a 1.5 mL
microcentrifuge tube containing 25 μL of 5% Na2EDTA
dissolved in water, as previously described [1]. The tube
was immediately pulse-vortexed at low speed and kept at
room temperature until the dissections of the brain and
gut were completed. Following the dissections, the blood
sample was visually examined for blood clots, the volume
of the collected blood was measured, and the sample was
stored in 20 μL aliquots at -75°C. The brain was dissected
out of the skull with a fine rongeur, immediately weighed
in phosphate-buffered saline (0.1 M PBS, pH 7.2) on a
precision balance, immersion-fixed overnight in 4% para-
formaldehyde in PBS at 4°C, allowed to sink in 30%
sucrose in PBS at 4°C, and processed as described below.
The gastrointestinal tract (the stomach through the rec-
tum) was dissected out of the trunk and allowed to relax
in PBS at 4°C for 10–13 days before photographed. The
distal tail was stored at -75°C for sex-genotyping. All anal-
yses were done blindly with respect to the values of the
other variables in the same individual mice.
Brain
Following cryoprotection, 17 brains (from 2 litters) were
embedded in 20% gelatin (type A; 275 bloom), immersed
in formalin with 20% sucrose for 3 hours at room temper-
ature, and sectioned coronally on a freezing microtome at
50 μm thickness into PBS in 96-well trays. Every lost sec-
tion was recorded and the percentage of missing sections
was not allowed to exceed 9%. The sections were immedi-
ately mounted onto glass slides coated with 0.5% gelatin
and 0.05% chromium potassium sulfate, allowed to air-
dry, Nissl-stained with 0.25% thionin, dehydrated in a
graded series of ethanols, cleared in Xylenes, and cover-
slipped with Permount. Since fixation and embedding
may alter tissue volume [54,55], care was taken to ensure
all brains and sections were exposed to the reagents for the
same length of time.
Images of serial sections were captured with a Zeiss Axio
Imager Z1 equipped with a color digital camera (AxioCam
HRC Rev. 2) using a 1× objective (Fig. 1A), imported into
the  Reconstruct  software (version 1.0.9.6; http://syn
apses.clm.utexas.edu/tools/index.stm), and the outline of
the left hippocampal complex was traced from the most
rostral section containing the pyramidal cells to the most
caudal section containing the dental gyrus (Figs. 39–64 of
[56]). In this rostro-caudal block, the traced regions
included the hippocampus proper, the fimbria, the den-
tate gyrus, the presubiculum, and the subiculum. If a sec-
tion was missing, the thickness of each of the two
neighboring sections was digitally increased by 50%. The
quality of tracing was assessed by rotating the 3D-recon-
struction and visually inspecting it for discontinuities (Fig.
1B). No digital smoothing was used.
Guts
To our knowledge, there are no standard protocols for
measuring gut length. Since the length of the gut increases
considerably after dissection (probably due to muscle
relaxation), we investigated this process experimentally
(see Results; Fig. 2) and developed a protocol that allowed
measuring gut length with high reliability. Following 10–
13 days of relaxation in 0.1 M PBS (pH 7.2) at 4°C, gas-
trointestinal tracts were digitally macro-photographed
(Fig. 2A) in 10 cm Petri dishes with shallow PBS (in order
to avoid vertical loops). A millimeter-ruler was included
in the images for scale. The images were imported into
Three-dimensional reconstruction of the hippocampal com- plex and sex-genotyping Figure 1
Three-dimensional reconstruction of the hippocam-
pal complex and sex-genotyping. (A) Representative 
Nissl-stained sections through the mouse brain used in 
three-dimensional reconstructions of the hippocampal com-
plex. Scale bar is 1 cm. (B) A three-dimensional reconstruc-
tion of the hippocampal complex. (C) The sry and myog 
(control) bands in female (F) and male (M) pups detected by 
sex-genotyping.
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Reconstruct, and the length of the gut was determined by
tracing both sides of the gut from the pylorus of the stom-
ach to the coecum and averaging the length of the two
traces. The remaining part of the gut was not measured
because it was difficult to control if the dissection
included the most distal part of the gastrointestinal tract.
This approach produced consistent measures over many
days (Fig. 2B) and was superior to obtaining only one
trace equidistant from the two sides of the gut.
Whole-blood tryptophan and 5-HT
The concentration of tryptophan and 5-HT in the blood
samples was measured by high-performance liquid chro-
matography (HPLC) as previously described [1]. Blood
samples were prepared by addition of 100 μL of 25%
ascorbic acid, 100 μL of 5% sodium metabisulfite, 10 μL
of 10 ng/μL N-methylserotonin (NMS, internal standard)
to frozen whole blood samples. After thawing and mixing,
75 μl of 3.4 M perchloric acid was added, the samples
were kept on ice for 10 minutes, centrifuged, and the
supernate was stored at -80°C until analyzed. Analysis
was performed by HPLC with fluorometric detection: a 25
× .46 Altex Ultrasphere column heated to 40°C was eluted
with a mobile phase consisting of 70% 0.1 M NaH2PO4
(pH 4.7) containing 150 mg/L octyl sulfate, 20% metha-
nol. Compounds were detected with a Shimadzu RF 10-
AXL fluorometer, with excitation and emission wave-
lengths of 285 and 345 nm, respectively, quantitated by
comparing peak heights ratios (analyte/NMS) to those
observed for standards, and concentrations expressed as
ng per mL. The neurochemicals were determined with typ-
ical intra- and inter-assay coefficients of variation of less
than 5% and 10%, respectively. In the final calculations,
the dilution of the collected blood in the Na2EDTA solu-
tion was factored out; therefore, the reported values repre-
sent tryptophan and 5-HT concentrations in the undiluted
whole blood.
Genotyping
Since sexing of young mice based on the appearance of
their external genitalia is difficult, the anogenital distance
can be used as a more reliable measure. In the present
study, several organs had to be rapidly extracted destroy-
ing the body in the process. Therefore, in order to avoid
ambiguity and human errors, mice were sexed by geno-
typing. This approach also allows permanent storage of
the extracted DNA which can be used for future analyses.
Genomic DNA was isolated with the DNA Isolation Kit
(Lamda, St. Louis, MO). Briefly, 1 cm of the tail was
digested in a lysis buffer at 56°C overnight, the DNA was
precipitated with ethanol, dissolved in 150 μL of Tris-
EDTA buffer (TE, pH 8.0), and stored at -20°C. The sry
region located on the Y chromosome was amplified by
polymerase chain reaction (PCR) using the HotStarTaq
Master Mix Kit (Qiagen, Valencia, CA). The sry primers
were 5'-AACAACTGGGCTTTGCACATTG-3' (forward)
and 5'-GTTTATCAGGGTTTCTCTCTAGC-3' (reverse), and
the control (myog) primers [57] were 5'-TTACGTC-
CATCGTGGACAGC-3' (forward), 5'-TGGGCTGGGTGT-
TAGTCTTA-3' (reverse). The PCR reaction mixture (50 μL)
contained 25 μL of the Master Mix, 1 μL (0.5 μM) of each
primer, 0.5 μL of the DNA sample, and 20.5 μL water. The
amplification was performed in a PxE thermal cycler
(ThermoFisher Scientific) with the following conditions:
initial activation at 95°C for 15 min, 33 cycles of amplifi-
cation (94°C for 40 sec; 60°C for 40 sec; 72°C for 1 min),
and final extension at 72°C for 9 min. The PCR products
were run at 120 V on 1.5% agarose gel in Tris-acetate-
EDTA buffer (TAE) containing 5% ethidium bromide and
digitally imaged with a DigiDoc-It UV transillumination
system (UVP, Upland, CA). The amplicon sizes were 146
bp/166 bp (sry, doublet) and 245 bp (myog) (Fig. 1C).
Statistical analysis
Statistical analysis was carried out in SPSS 16.0.2 (SPSS
Inc., Chicago, IL). Conceptually, the analysis was based
on the general linear model (GLM) that considers correla-
Gut relaxation Figure 2
Gut relaxation. (A) The relaxation of the same representa-
tive gastrointestinal tract kept in PBS at 4°C and photo-
graphed at 0, 2, 4, and 13 days after dissection. 
Abbreviations: s, stomach; c, coecum; r, rectum; scale bar is 1 
cm. (B) The relaxation of five guts (measured from the 
pylorus of the stomach to the coecum) kept in PBS at 4°C 
and measured over the course 34 days. The dashed line rep-
resents the theoretical relaxation (Eq. 2) of a gut with the ini-
tial length of 150 mm. (C) The relationship between the 
current gut length and the increase in gut length per day. The 
data points were obtained from the five guts used in (b); for 
better precision of the linear regression (line), only the initial 
6 days were included in the analysis. The rate of relaxation 
was calculated as the absolute difference in length between 
the current day and the next day.
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tion, ANOVA and ANCOVA to be special cases of linear
regression [58]. Residuals were tested for normality with
the Shapiro-Wilk test (with the level of significance of p <
0.05) and for independence with the Durbin-Watson test
(DW; independence was assumed if the DW value was in
the 1–3 range).
Unless otherwise noted, the forced-entry method was
used in linear regression. A non-linear relationship
between two variables was considered to be linear "in the
parameters" [58], which allowed using standard GLM
methods. In backward (stepwise) regression, Fisher's F
critical value for variable removal was set at the standard
significance level of 0.1. Pearson's correlation between
two variables was used if the residuals of the linear regres-
sion between these two variables were normally distrib-
uted (otherwise, the Mann-Whitney test was used). The
emphasis on the normality of residuals rather than of var-
iables themselves follows the standard approach in GLM
models. Specifically, it allows treating Student's inde-
pendent t-test as a special case of Pearson's correlation
between a continuous variable and a dichotomous varia-
ble (e.g., sex; Table 1).
Results
Data screening
The collected data (Additional file 1) for each of the vari-
ables were screened for quality blindly with respect to the
values of the other variables. As described below, objec-
tive criteria were used to eliminate some cases from fur-
ther analysis. Since in all reconstructed cases the
percentage of missing sections in the hippocampal com-
plex did not exceed 9%, all of the reconstructions were
used. Cases with guts clearly damaged during dissection
(e.g., split into more than two pieces) were not used in
further analyses that included gut length as a variable. We
investigated whether the presence of blood clots in some
blood samples affected their tryptophan or 5-HT concen-
tration. The mean tryptophan concentrations were not
significantly different in the samples with and without
blood clots (t(61) = 0.47, p = 0.644), but the mean 5-HT
concentration was significantly lower in the former group
(t(61) = 2.44, p = 0.018). Therefore, cases with blood clots
(N  = 5) were disregarded in all further analyses that
included tryptophan or 5-HT as variables.
The collected blood volume varies from case to case and is
strongly affected by the constriction of major blood ves-
sels, the angle between the trunk and the collecting tube,
and other factors. We therefore asked whether the amount
of the collected blood correlated with the measured tryp-
tophan and 5-HT concentrations (if all other parameters
are equal and the measurements are accurate, no signifi-
cant effect should be observed). The correlation between
blood sample volume and blood 5-HT concentration was
significant (r = -0.385, p = 0.003). However, the collected
blood volume is also influenced by body size. Therefore,
we calculated the partial correlation between blood sam-
ple volume and blood 5-HT concentration controlling for
body mass and found that this correlation became non-
significant (r = -0.085, p = 0.532). In contrast, the partial
correlation between body mass and blood 5-HT concen-
tration controlling for blood sample volume was highly
significant (r = -0.495, p = 9·10-5). Therefore, all of these
cases (N = 58) were used in further analyses that included
tryptophan or 5-HT as variables. The relationship between
body mass and blood 5-HT concentration was investi-
gated further.
ANOVA showed significant litter effects on body mass
(F5,57 = 40.3, p < 10-6), brain mass (F5,57 = 15.5, p < 10-6),
hippocampal volume (F1,15 = 7.9, p = 0.013), blood tryp-
tophan levels (F5,52 = 10.8, p < 10-6), blood 5-HT levels
(F5,52 = 16.0, p < 10-6), and a near-significant litter effect
on gut length (F5,27 = 2.54, p = 0.052).
Gut relaxation
After dissection, the length of the gut increases over the
course of several days until it reaches a plateau (Fig. 2A,
B). We followed the relaxation of 5 guts in PBS at 4°C and
plotted the rate of their length increase as a function of
their current length (Fig. 2C). Linear regression revealed a
strong relationship between these variables (R2 = 0.811,
F1,28 = 120.5, p < 10-6); the residuals were normally distrib-
uted (p = 0.18) and independent (DW = 2.45). This linear
relationship suggests that gut relaxation can be modeled
with the differential equation
dL/dt = k (γL0 - L), (1)
where dL/dt is the current length increase rate as a function
of the current gut length (L), L0 is the initial gut length on
the dissection day, γL0 is the final gut length (where γ > 1
is a constant independent of L0), and k  is the length
increase rate constant. Based on Eq. (1), we reanalyzed the
gut relaxation data with linear regression using dL/dt as
the dependent variable and L0 and L as the two predictor
variables. Since according to Eq. (1) dL/dt = 0 when L0 = L
= 0, the intercept of the regression line was fixed at the axis
origin. The regression revealed that Eq. (1) well describes
the relaxation process, since L0 and L explained virtually
all variance in the length increase rate (R2 = 0.947, F2,28 =
250.8, p < 10-6). The residuals were normally distributed
(p = .993) and independent (DW = 1.72). The regression
yielded k = 0.49 day-1 and γ = 1.54. Since the solution of
Eq. (1) is
L(t) = γL0 + L0e-kt (1 - γ), (2)
plugging the obtained numerical k and γ values into Eq.
(2) shows that, at 4°C, the gut reaches 95% of its finalBMC Physiology 2009, 9:4 http://www.biomedcentral.com/1472-6793/9/4
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length (1.54 L0) in 4 days and 99% in 7 days. In the
present study, we allowed guts to relax for 10–13 days;
however, shorter relaxation times (6–8 days) should be
sufficient to obtain accurate measurements.
Cross-correlations
In the initial analysis, the residuals of the linear regression
between each of the variable pairs were tested for normal-
ity. Of 7 pairs that failed the normality test (irrespective of
which of the two variables was the non-dichotomous
dependent variable), 5 included at least one of the "ratio
variables" ("brain mass/body mass" or "blood 5-HT con-
centration/blood tryptophan concentration"). This result
is expected since the ratio of two normally distributed var-
iables is not normally distributed and can even be bimo-
dal [59]. Based on these results, the Mann-Whitney test
was used to compare the "ratio variables" in the two sex
groups; for all other variables, Student's t-test was used.
Likewise, Spearman's correlation coefficient was used to
correlate two variables when either of them was a "ratio
Table 1: Differences between the sex groups and the cross-correlations between the variables
M
(g)
BM
(g)
BM/M HC
(mm3)
Trp
(ng/mL)
5-HT
(ng/mL)
5-HT/
Trp
Gut
(mm)
Sex F < M F < M F > M F < M F < M F > M F > M* F > M
.185 .273 .325 .286 .584 .245 .040 .861
63 63 63 17 58 58 58 33
M .768** -.825** .662** -.089 -.594** -.304* .688**
< 10-6 < 10-6 .004 .507 10-6 .020 10-5
63 63 17 58 58 58 33
BM -.165 .619** .056 -.433** -.262* .400*
.196 .008 .676 .001 .047 .021
63 17 58 58 58 33
BM/M -.571* .229 .465** .315* -.745**
.017 .084 2·10-4 .016 10-6
17 58 58 58 33
HC -.638** -.505* -.124 .427
.008 .046 .649 .146
16 16 16 13
Trp .116 -.430** -.293
.387 .001 .110
58 58 31
5-HT .818** -.264
< 10-6 .152
58 31
5-HT/Trp -.004
.983
31
N 63 63 63 17 58 58 58 33
Mean 6.511 .387 .061 8.127 16424 2069 .128 221.30
STD .954 .028 .008 1.054 2439 536 .037 11.25
Abbreviations: M, body mass; BM, brain mass; HC, volume of the hippocampal complex; Trp, blood tryptophan concentration; 5-HT, blood 5-HT 
concentration; Gut, length of the relaxed gut; N, total number of cases; STD, standard deviation. The two sex groups were compared using the 
exact Mann-Whitney test if the variable was BM/M or 5-HT/Trp; otherwise, Student's independent t-test was used. Spearman's correlation was 
used if either of the two non-dichotomous variables was BM/M or 5-HT/Trp; otherwise, Pearson's correlation was used. In the sex row, the 
"greater than" ("less than") sign indicates that the mean of the female group was greater (less) than the mean of the male group. In all other cells, the 
first number is the value of the correlation coefficient. In all cells, the second (bold) number is the significance of the corresponding test. In all cells, 
the third number is the total number of cases used in the test. The residuals of the linear regression with sex as the predictor variable and M or 5-
HT as the dependent variable were not normally distributed (p = 6·10-5 and 8·10-6, respectively). Therefore, the differences between the mean M 
and 5-HT values in the two sex groups were retested with the exact Mann-Whitney test, which confirmed they were not significant (p = 0.124 and 
0.168, respectively).BMC Physiology 2009, 9:4 http://www.biomedcentral.com/1472-6793/9/4
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variable"; otherwise, Pearson's correlation was used. The
results of these calculations are given in Table 1.
In the interpretation of the results, the Bonferroni correc-
tion for multiple tests was used. The type I error (α = 0.05)
was divided by the total number of tests (36; Table 1) to
yield the significance level of α* = 0.0013. As expected,
highly significant positive correlations were found
between body mass and brain mass (p  < 10-6) and
between body mass and gut length (p  = 10-5). Also, a
highly significant negative correlation was found between
body mass and the brain/body mass ratio (p < 10-6), pos-
sibly due to allometric scaling of brain size.
The cross-correlational analysis revealed a strong negative
correlation between body mass and blood 5-HT levels (p
= 10-6). Also, significant correlations were found between
brain mass and blood 5-HT levels, and between the brain/
body mass ratio and blood 5-HT levels (p = 0.001 and
0.0002, respectively). Since body mass, brain mass and
the brain/body mass ratio cross-correlate, we next tested
which of the three variables or their linear combinations
could best predict blood 5-HT levels by using stepwise
(backward) linear regression. It revealed that body mass,
alone, could best predict blood 5-HT levels (Fig. 3A) and
that inclusion of the other two variables did not statisti-
cally improve this prediction. This model yielded R2 =
0.352 (F1,56 = 30.5; p = 10-6; adjusted R2 = 0.341); the
residuals were normally distributed (p = 0.21) and inde-
pendent (DW = 1.15). Since two males had unusually
high blood 5-HT concentration (over 3500 ng/mL), we
next investigated the origin of these outliers and their
influence on the regression model. No blood clots were
observed in these samples (all cases with blood clots had
been eliminated prior to the analysis) and the tryptophan
concentration measured in these same samples was in the
normal range (Fig. 3B). Since Cook's distances (Cook's D)
can be used to estimate the influence of individual cases
on a regression model, we calculated this statistic for all
regression points and found the largest Cook's D to be
0.66, below the critical value of 1. While the two cases
could not be eliminated based on any of these objective
criteria, we next excluded these two cases and recalculated
the regression model. After this adjustment, blood 5-HT
concentration was still best predicted by body mass (R2 =
0.210; F1,54 = 14.3; p = 0.00039; adjusted R2 = 0.195).
All pups with body mass less than 5 g came from the same
litter. Their tissues were collected at PD14, the same devel-
opmental time at which the other four litters were proc-
essed. The litter was normal size (14 pups; another litter
had the same number of pups) and the pups showed no
gross anatomical abnormalities. These pups were used in
all the other analyses (including the reconstruction of the
hippocampal complex) and did not appear to be outliers
there (Fig. 3C, D). The correlation between body mass and
blood 5-HT remained significant if only the litter means
were considered (Fig. 4A).
Next, we analyzed the strong correlation between gut
length and the brain/body mass ratio (p = 10-6). Since the
residuals of the linear regression between these two varia-
bles were not distributed normally (p = 0.03), we modeled
their relationship with a quadratic polynomial (Fig. 3C).
The regression yielded R2 = 0.621 (F2,30 = 24.6, p < 10-6;
adjusted R2 = 0.596); the residuals were normally distrib-
uted (p = 0.26) and independent (DW = 1.16). The con-
stant at the quadratic term was significantly different from
zero (t(30) = 3.36, p = 0.002), further supporting the non-
linearity of the relationship. The correlation between gut
length and the brain/body mass ratio remained significant
if only the litter means were considered (Fig. 4B).
The correlation between blood tryptophan concentration
and hippocampal complex volume did not meet the sig-
nificance criterion after the Bonferroni correction. How-
ever, it was highly significant considered separately (Fig.
3D). The linear regression yielded R2 = 0.407 (F1,14 = 9.63,
p = 0.008; adjusted R2 = 0.365); the residuals were nor-
mally distributed (p  = 0.58) and independent (DW =
1.40).
Discussion
To date, relationships among body mass, brain mass, gut
length, and whole-blood tryptophan and 5-HT levels have
not been systematically investigated in a genetically uni-
form population of any mammalian species. Table 1 pro-
vides information for future top-down [2,25] and
bottom-up (e.g., structural equation modeling) studies
and can also be used in the design of multidimensional
experiments where a priori considerations of statistical
power are important.
We found a strong negative correlation between body
mass and whole-blood 5-HT levels. The strength of this
relationship was influenced by the presence of several
pups with low body mass but no gross anatomical abnor-
malities. The elevated blood 5-HT levels were unlikely to
be caused by developmental delay, since blood 5-HT lev-
els increase, not decrease, during postnatal development
in mice [1]. It has been reported that extremely low levels
of maternal peripheral 5-HT result in smaller mouse
embryos that also exhibit abnormalities in many organ
systems [60,61]. It is intriguing to speculate that a less
severe decrease in maternal peripheral 5-HT may also
result in reduced body mass and compensatory overpro-
duction of peripheral 5-HT in the offspring. However,
peripheral administration of the immediate 5-HT precur-
sor 5-hydroxytryptophan (5-HTP) to pregnant rats also
leads to embryos with reduced body mass [62].BMC Physiology 2009, 9:4 http://www.biomedcentral.com/1472-6793/9/4
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Relationships between highly correlated variables Figure 3
Relationships between highly correlated variables. (A) The relationship between body mass and blood 5-HT concentra-
tion. The long and short arrows indicate two potential outliers with high blood 5-HT concentration. (B) The blood tryptophan 
concentration of the two potential outliers in (A) appears to be normal (the corresponding arrows). (C) The relationship 
between gut length and the brain/body mass ratio. (D) The relationship between blood tryptophan concentration and the vol-
ume of the hippocampal complex.
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The observed relationship between body mass and blood
5-HT levels is predicted by our theoretical model of plate-
let 5-HT levels [2]. According to the model (equations
(22) and (27) of [2]), platelet 5-HT levels (P) are given by
the following equation:
P = [a Q (b + Ωg
-1) + c]-1,
where Q is the total cardiac output, Ωg is the volume of the
gut wall, and where the positive a, b, and c can be consid-
ered constant in this study. The cardiac output is likely to
be directly proportional to body mass (i.e., Q = kM, where
M is body mass and k is a positive constant). Gut length
also scales with body mass (Table 1), but an increase in
body mass is unlikely to increase gut length by the same
factor. Therefore, the volume of the gut wall may scale as
Ωg= rM (1/h) + s, where r > 0, s ≥ 0, and h ≥ 1 are constants.
This allows expressing P as a function of M and, since the
derivative of P with respect to M is always negative (i.e.,
dP/dM < 0), platelet 5-HT concentration should decrease
as body mass increases. Importantly, this relationship
may not hold true for developmental processes [1]
because other parameters, here considered constant (e.g.,
the levels of extracellular 5-HT in the gut wall, the platelet
5-HT uptake rate constant; see Janušonis (2008)), may
undergo developmental changes.
Body mass is almost never controlled for in experimental
studies on the platelet hyperserotonemia of autism
[9,11,12]. In light of the present findings, including body
mass as a covariate may reduce uncontrolled variability in
platelet 5-HT levels. Recent findings show that low birth
mass may carry an increased risk for ASDs [63] and that
head circumference strongly correlates with body mass in
ASD patients [64]. Intriguingly, the maturation of thalam-
ocortical projections appears to be influenced by body
mass in normal mice [65].
We found a non-linear relationship between gut length
and the brain/body mass ratio. While there appears to be
little association between the brain/body mass ratio and
the relaxed gut length if guts are average length, short guts
predict a higher brain/body mass ratio (Fig. 3C). The bio-
logical nature of this relationship is unclear. It is conceiv-
able that the length of the gut modulates how much
tryptophan reaches the systemic blood circulation and,
since tryptophan can cross the BBB, its availability in the
brain may affect brain growth through 5-HT synthesis
[66]. Intriguingly, it has been recently hypothesized that a
decrease in gut length has had a major impact on the evo-
lution of the human brain [67,68].
The analysis also suggested a tentative relationship
between blood tryptophan levels and the volume of the
developing hippocampal complex. Tryptophan depletion
is known to affect the development and function of the
hippocampus [69-71]. Our results suggest that even rela-
tively small, natural fluctuations of blood tryptophan lev-
Relationships between the litter means of highly correlated variables Figure 4
Relationships between the litter means of highly correlated variables. (A) The relationship between the litter means 
of body mass and blood 5-HT concentration. (B) The relationship between the litter means of gut length and the brain/body 
mass ratio. In (A) and (B), point #N (M) represents litter N with M cases analyzed; the horizontal and vertical bars represent 
the standard errors of the means.
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els may modulate its size. Interestingly, at PD14, the mean
blood tryptophan concentration in the CD-1 strain
(16424 ng/mL) was considerably higher than that in the
C57BL/6 strain (11563 ng/mL) [1]. Since the tryptophan
levels were assessed by the same method in both studies,
a statistical comparison between them suggests that this
difference between the two strains is significant (t(66) =
6.17, p = 4.7·10-8). It would be interesting to know if the
mean volumes of the hippocampal complex also differ in
these strains.
No sex differences were observed with regard to all varia-
bles. The marginally significant sex difference between the
blood 5-HT/tryptophan ratios could be spurious consid-
ering the large number of tests. Also, the correlation
between blood tryptophan and 5-HT was non-significant,
consistent with previous reports in humans [34] and in
C57BL/6 mice at postnatal day 14 [1].
The strong statistical relationships found in the present
study should be cross-validated in other mouse strains
and (when feasible) in humans. It should be noted that all
of the reported relationships are empirical and do not
imply direct causality; however, these findings may stim-
ulate further experimental research where causality in
addressed. For instance, mice lacking the serotonin 5-
HT1A receptor show elevated levels of anxiety [72] and
develop an autistic-like blood hyperserotonemia [1].
While these two phenomena may appear unrelated, they
may be explained by the expression of 5-HT1A receptors
both in the brain [51,73,74] and in the gut [75]. Serotonin
5-HT4 receptors play important roles in the developing
brain [76,77] and the gut [44,78], and recently 5-HT4
mRNA has been reported in blood platelets [79]. There-
fore, altered expression of 5-HT4 receptors may simultane-
ously affect all of these subsystems, even if they are
separated by the BBB. Experimental methods, used in
combination with modern statistical approaches, can pro-
vide important information about the interactions among
components of the peripheral and central 5-HT systems,
which are often studied in isolation.
Conclusion
The study provides information on the covariance struc-
ture of several variables related to the central and periph-
eral serotonin systems. In particular, the results indicate
that body mass should be included as a covariate in stud-
ies on platelet 5-HT levels and they also suggest a link
between brain growth and gut length.
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